Ina A. Eilertsen
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 14
- Colorectal Cancer Treatments and Studies 11
-
- Genetic factors in colorectal cancer 11
- Co-authors
- Ragnhild A. Lothe (25 shared papers)Peter W. Eide (12 shared papers)Stine A. Danielsen (11 shared papers)Guro E. Lind (4 shared papers)Merete Hektoen (8 shared papers)M. Eknæs (2 shared papers)Anita Sveen (22 shared papers)Arild Nesbakken (17 shared papers)
- Journals
- Genome Medicine (3 papers)International Journal of Cancer (3 papers)Cancer Letters (2 papers)Molecular Oncology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- NorwaySwedenUnited States
In The Last Decade
Ina A. Eilertsen
24 papers receiving 1.8k citations
Ina A. Eilertsen's Hit Papers
Peers
Comparison fields: 5 of 87
- Cancer Research 428
- Oncology 664
- Pathology and Forensic Medicine 319
- Molecular Biology 858
- Immunology 131
Countries citing papers authored by Ina A. Eilertsen
This map shows the geographic impact of Ina A. Eilertsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina A. Eilertsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina A. Eilertsen more than expected).
Fields of papers citing papers by Ina A. Eilertsen
This network shows the impact of papers produced by Ina A. Eilertsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina A. Eilertsen. The network helps show where Ina A. Eilertsen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ina A. Eilertsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epigenetic and genetic features of 24 colon cancer cell lines Hit paper breakdown → | 2013 | 698 |
| 2 | Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies Hit paper breakdown → | 2017 | 288 |
| 3 | 2017 | 175 | |
| 4 | 2014 | 68 | |
| 5 | 2017 | 66 | |
| 6 | 2018 | 64 | |
| 7 | 2012 | 63 | |
| 8 | 2016 | 55 | |
| 9 | 2021 | 42 | |
| 10 | 2018 | 36 | |
| 11 | 2018 | 33 | |
| 12 | 2020 | 29 | |
| 13 | 2021 | 26 | |
| 14 | 2019 | 22 | |
| 15 | 2018 | 21 | |
| 16 | 2017 | 16 | |
| 17 | 2019 | 16 | |
| 18 | 2019 | 13 | |
| 19 | 2018 | 12 | |
| 20 | 2023 | 11 |
About Ina A. Eilertsen
Ina A. Eilertsen is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Molecular Biology and Neurology, having authored 26 papers that have together received 1.8k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (11 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer Genomics and Diagnostics (8 papers), RNA modifications and cancer (4 papers), Neurofibromatosis and Schwannoma Cases (3 papers), Cancer-related molecular mechanisms research (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Mycobacterium research and diagnosis (2 papers). The work is most often cited by research in Cancer Research (428 citations), Oncology (664 citations), Pathology and Forensic Medicine (319 citations), Molecular Biology (858 citations) and Immunology (131 citations). Ina A. Eilertsen has collaborated with scholars based in Norway, Sweden and United States. Frequent co-authors include Ragnhild A. Lothe, Peter W. Eide, Stine A. Danielsen, Guro E. Lind, Merete Hektoen, M. Eknæs, Anita Sveen, Arild Nesbakken, Jarle Bruun and Kaja C. G. Berg. Their work appears in journals such as Genome Medicine, International Journal of Cancer, Cancer Letters, Molecular Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.